Sort by
Keyphrases
Cancer Vaccine
100%
Tumor
100%
Preventive Vaccine
50%
Human Trials
50%
Therapeutic Vaccine
40%
Prophylactic Vaccine
40%
Stephen
40%
Developing World
30%
Breast Cancer
30%
Frameshift
30%
Gene Vaccine
30%
Self-antigens
30%
Dog Vaccine
30%
Vaccination
20%
Neoantigen
20%
Frameshift Neoantigens
20%
Human Vaccines
20%
Immune Response
20%
Personalized Medicine
20%
Checkpoint Inhibitors
20%
Tumor Antigen
20%
MRNA Level
20%
Proton Beam Therapy
20%
Transcription-translation
10%
Population at Risk
10%
Co-inventor
10%
Pediatric Vaccines
10%
Economically Feasible
10%
Colon Tumor
10%
Advanced Cancer
10%
Administrators
10%
Age-adjusted Mortality Rates
10%
Translation Quality Assessment
10%
Breast Cancer Vaccine
10%
Will of the People
10%
Test Population
10%
Immunotherapeutics
10%
Specific Infection
10%
Route of Administration
10%
Heavy Ion Therapy
10%
Tumor Sequencing
10%
Difficult Problem
10%
Preventing Infection
10%
Colon Cancer
10%
Venture Capitalists
10%
HPV Vaccine
10%
Advanced Radiation Therapy
10%
High Cost
10%
Asia
10%
Patient-specific
10%
Artemis
10%
Commercial Products
10%
NIH Funding
10%
Operative
10%
Anticancer Strategy
10%
Foreign Antigen
10%
DNA Replication
10%
Cancer Alliances
10%
Tumor Cells
10%
Clinical Validation
10%
Return on Investment
10%
Infectious Disease Vaccine
10%
Immune-suppressive
10%
Tumor-induced Immune Suppression
10%
Coding Region
10%
Non-communicable Diseases
10%
Sequencing Effort
10%
Infectious Agents
10%
Efficacy Trial
10%
Heart Disease
10%
Cancer Genome Sequencing
10%
Microsatellite Repeats
10%
Prophylactic Cancer Vaccine
10%
Tumor Relapse
10%
Vaccine Technology
10%
Radiation Therapy
10%
NorA
10%
Statins
10%
Double-stranded RNA
10%
Phase I Trial
10%
Unique Solution
10%
Vaccine Trial
10%
Liver Cancer
10%
Physician-scientist
10%
Protein Quality Control
10%
People with Cancer
10%
Error-prone
10%
Viral Infection
10%
Cancer Relapse
10%
Protection Studies
10%
High-risk Strategy
10%
In Cancer
10%
Fatality
10%
Virus
10%
Hepatitis B Vaccine
10%
Success Probability
10%
Cancer-related
10%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Cancer Vaccine
100%
Neoplasm
48%
Breast Cancer
14%
Therapeutic Vaccine
14%
Infection
11%
Mouse
7%
Clinical Trial
7%
Vaccination Policy
7%
Tumor Antigen
7%
Immunology and Microbiology
Vaccine Efficacy
100%
Cancer Vaccine
100%
Neoantigen
12%
Tumor Antigen
6%
Solution and Solubility
6%
Proton Radiation
6%
Vaccination Policy
6%
Immune Response
6%
Mouse
6%